Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
HealthcareAdd-on
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Kailera Therapeutics Upsized IPO Raises $625M
Announced
HealthcareOther
Deal Overview
Kailera Therapeutics’ upsized IPO is reported to bring in $625M to fund a pipeline of injectable and oral obesity drugs. The deal is described as an IPO intended to support development of obesity therapeutics.
Key Details
- Target
- Kailera Therapeutics
- Deal Size
- Over $100M
Related Deals
Marksans Pharma Acquires Netherlands-Based QliniQ B.V. for €7.5m to Expand EU Reach - scanx.trade
HealthcareAdd-on
Marksans Pharma→QliniQ
Jun 1, 2026
Altruix Acquired By Frazier Healthcare Partners And Randy Hyun Appointed CEO - Pulse 2.0
HealthcareOther
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
HealthcareOther
Signos
May 31, 2026
Sterling Bay Partnership Secures $290M Financing for Sorrento Mesa’s Pacific Center
HealthcareCaliforniaOther
Sterling Bay→Pacific Center
May 29, 2026